Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists

Rachael Lester1, Ying Lu, Jeanne Tung

  • 1*Mayo Medical School, Mayo Clinic, Rochester, MN. †Division of Pediatric Gastroenterology, Cohen Children's Medical Center of New York, Hofstra North Shore-Long Island Jewish School of Medicine, Great Neck, NY ‡Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Insights

Pediatric gastroenterologists show varied vaccination practices for patients with inflammatory bowel disease. Key barriers include poor care coordination and limited access to immunization records.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Public Health

Background:

  • Inflammatory bowel disease (IBD) management requires careful consideration of vaccination status.
  • Immunization guidelines aim to protect vulnerable pediatric IBD patients from vaccine-preventable diseases.

Purpose of the Study:

  • To assess current vaccination practices among pediatric gastroenterologists for IBD patients.
  • To identify barriers hindering adherence to established immunization guidelines.

Main Methods:

  • Electronic survey distributed to 657 physicians from 129 institutions.
  • Data collected from 178 responding pediatric gastroenterologists.

Main Results:

  • Significant practice variation exists in vaccine assessment timing and methods.
  • Influenza, hepatitis B, and varicella vaccines were most commonly assessed.
  • Barriers include poor primary care coordination (41%), limited record access (36%), and lack of in-house vaccine availability (55%).

Conclusions:

  • Pediatric gastroenterologists exhibit diverse approaches to immunizations in IBD care.
  • Systemic barriers impede consistent adherence to vaccination protocols.
  • Improved care coordination and record accessibility are crucial for enhancing IBD patient immunization rates.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
1
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
905
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
4
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
1.0K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2